abstract: In this study, we aimed to investigate modulation of glucose uptake by the HTR-8/SVneo human first-trimester extravillous trophoblast cell line by a series of compounds and to study its consequences upon cell proliferation, viability and migration. We observed that uptake of 3 H-deoxy-D-glucose ( 3 H-DG; 10 nM) was time-dependent, saturable, inhibited by cytochalasin B (50 and 100 mM), phloretin (0.5 mM) and phloridzin (1 mM), insulin-insensitive and sodium-independent. In the short term (30 min), neither 5-HT (100-1000 mM), melatonin (10 nM) nor the drugs of abuse ethanol (100 mM), nicotine (100 mM), cocaine (25 mM), amphetamine (10 -25 mM) and 3,4-methylenedioxy-N-methamphetamine (10 mM) affected 3 H-DG uptake, while dexamethasone (100-1000 mM), fluoxetine (100-300 mM), quercetin, epigallocatechin-3-gallate (30 -1000 mM), xanthohumol (XH) and resveratrol (1-500 mM) decreased it. XH was the most potent inhibitor [IC 50 ¼ 3.55 (1.37-9.20) mM] of 3 H-DG uptake, behaving as a non-competitive inhibitor of 3 H-DG uptake, both after short-and long-term (24 h) treatment. The effect of XH (5 mM; 24 h) upon 3 H-DG uptake involved mammalian target of rapamycin, tyrosine kinases and c-Jun N-terminal kinases intracellular pathways. Moreover, XH appeared to decrease cellular uptake of lactate due to inhibition of the monocarboxylate transporter 1. Additionally, XH (24 h; 5 mM) decreased cell viability, proliferation, culture growth and migration. The effects of XH upon cell viability and culture growth, but not the antimigratory effect, were mimicked by low extracellular glucose conditions and reversed by high extracellular glucose conditions. We thus suggest that XH, by inhibiting glucose cellular uptake and impairing HTR-8/SVneo cell viability and proliferation, may have a deleterious impact in the process of placentation.
Introduction
The placenta provides the interface between the fetal and maternal environments, being involved in the exchange of gases, nutrients and waste products between the mother and the growing fetus (Cross, 1998; Fowden et al., 2008) , serving as an endocrine organ by producing several pregnancy-associated hormones and growth factors and ensuring the protection of the fetus from maternal immune attack (Regnault et al., 2002) . Early after fertilization, the process of blastocyst implantation begins along with differentiation of trophoblastic stem cells into two cell lineages: (a) villous cytotrophoblasts that fuse to form the multinucleated syncytiotrophoblasts, which ensure placental endocrine, protective and transport functions, and (b) extravillous trophoblasts (EVTs), which are the main participants in the process of placentation (Vicovac et al., 1995; Ji et al., 2013) . Placentation is a continuous and highly regulated process that begins right after fertilization and ends only after delivery (James et al., 2012 ). An adequate placentation and a consequent adequate nutrient supply to the fetus are crucial factors for fetal development and growth and for pregnancy outcome. Such critical importance is evident as fetal growth restriction (FGR) is commonly characterized by impaired uterine blood flow and placental development causing reduced fetal nutrient uptake as well as fetal hypoxia (James et al., 2012) . EVTs are fully specialized trophoblasts exhibiting an invasive and proliferative phenotype. They perform the anchorage of the chorionic villi into the uterine wall and actively regulate the process of uterine spiral arteries remodeling, a process that ends up with the establishment of the utero-placental blood flow (Ji et al., 2013) .
Glucose is a major substrate for fetal and placental energy metabolism. However, gluconeogenesis in the feto-placental unit is minimal (Magnusson et al., 2004) . Therefore, the supply of glucose from the maternal circulation is mandatory for the process of placentation and for the normal fetal development and growth (Baumann et al., 2002; Carter, 2012) . Despite such importance, glucose homeostasis in first-trimester trophoblasts and the implications of this mechanism in the process of placentation are still largely unexplored. Glucose transport at the cell membrane level involves two structurally and functionally distinct families of transporters, namely sodium-dependent glucose co-transporters (SGLTs, gene symbol SLC5A) (Wright, 2001 ) and facilitative Na + -independent sugar transporters [glucose transporter (GLUT) family, gene symbol SLC2A], a group comprising at least 12 isoforms (GLUT1-GLUT12) (Illsley, 2000) . Among the 12 isoforms, GLUT1 is a ubiquitous isoform, expressed in almost all tissues and it is regarded as the constitutive form of the glucose transporter in the placenta from implantation to term (Illsley, 2000) . Pregnant women are exposed to several bioactive compounds including: (a) polyphenols through ingestion of vegetables, fruits and beverages (Manach et al., 2004) , (b) therapeutic compounds, since many pregnant women take medication for the treatment of various conditions such as epilepsy, hypertension, depression, human immunodeficiency virus and gestational diabetes and (c) drugs of abuse and alcohol, which are known to exert deleterious effects on the fetus (Ganapathy, 2011) . Nothing was known concerning the characteristics of glucose uptake by first-trimester EVT cells and the implications of this mechanism in the placentation process; therefore, we herein intended to study glucose uptake in a human first-trimester EVT cell line (HTR-8/SVneo cells), its modulation by several compounds, such as dietary compounds, therapeutic agents and drugs of abuse, and whether the modulation of glucose transport by these compounds interferes with the placentation process.
Materials and Methods

Materials
The materials listed below were used in the study. The drugs to be tested were dissolved in water (ascorbic acid, cocaine, DG, FLUOX, MELAT, NADH, (2)-nicotine, pargyline, 5-HT), 1% (v/v) acetic acid (sulforhodamine B), 100% (v/v) ethanol (DEXA, PHZ, XH), 100% (v/v) methanol (amphetamine, MDMA, PHT), DMSO (CAF, CYT B, EGCG, genistein, LY 294002, PD 98059, QUE, rapamycin, RESV, SB 203580, SP 600125 and TEO) or 0.01 M HCl (insulin). The final concentration of these solvents was 1% (v/v) in pre-incubation and incubation buffer and in the culture media. Controls for these compounds were run in the presence of the respective solvents. Stock solutions (amphetamine 7.4 mM, cocaine 100 mM, CYT B 10 mM, EGCG 100 mM, genistein 100 mM, insulin 0.1 mM, LY 294002 10 mM, MDMA 5.2 mM, pargyline 10 mM, PD 98059 10 mM, PHT 100 mM, PHZ 100 mM, QUE 100 mM, rapamycin 1 mM, RESV 100 mM, SB 203580 10 mM, 5-HT 100 mM, SP 600125 10 mM and XH 100 mM) were stored at 2208C, unless otherwise stated.
Human first-trimester EVT cell culture (HTR-8/SVneo cells) HTR-8/SVneo cells were generously provided by Dr Charles H. Graham (Department of Anatomy & Cell Biology, Queen's University at Kingston, Canada) (Graham et al., 1993) and were used between passage number 72 and 86. Cells were maintained in a humidified atmosphere of 5% CO 2 -95% air and were grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum and 1% antibiotic/antimycotic solution. The culture medium was changed every 2 -3 days and the culture was split every 7 days. For sub-culturing, the cells were removed enzymatically (0.05% trypsin-EDTA, 5 min, 378C), split 1:6 ratio and sub-cultured in plastic culture dishes (21 cm 2 ; diameter 60 mm, TPP w , Trasadingen, Switerzland). For transport experiments, for glucose metabolism assessment and for quantification of cell viability and migration, HTR-8/SVneo cells were seeded on 24-well plastic cell culture dishes (2 cm 2 ; Ø 16 mm; TPP w ), and were used after 7 -11 days in culture (90-100% confluence). For proliferation and culture growth assays, cells were seeded on 24-well plastic cell culture dishes (2 cm 2 ; Ø 16 mm; TPP w ), and were used after 5 days in culture (70-80% confluence). For RNA and protein extraction, cells were seeded in plastic culture dishes (21 cm 2 ; Ø 60 mm; TPP w ) and were used after 7 -11 days in culture (90-100% confluence). The cell medium was free of fetal calf serum for 24 h before the experiments.
Transport studies
Transport experiments were performed in glucose-free-HEPES-buffered saline (GF-HBS) buffer (composition (all mM): 20 HEPES -NaOH, 5 KCl, 140 NaCl, 2.5 MgCl 2 , 1 CaCl 2 and pH 7.4). Initially the culture medium was aspirated and the cells were washed with buffer at 378C; then the cell monolayers were preincubated for 20 min with buffer at 378C. Uptake was initiated by the addition of 0.2 ml buffer at 378C containing 10 or 20 nM 3 H-DG (except in experiments for determination of kinetics of 3 H-DG uptake). Incubation was stopped after 10 min (except in the timecourse experiments) by removing the incubation medium, placing the cells on ice and rinsing the cells with 0.5 ml ice-cold buffer). In experiments for determination of kinetics of 3 H-DG uptake, cells were incubated for 10 min with increasing concentrations (0.01-10 000 mM) of 3 H-DG. In 14 C-BT (10 mM) uptake experiments, an incubation time of 3 min was used. At the end of the incubation period, the cells were then solubilized with 0.3 ml 0.1% (v/v) Triton X-100 (in 5 mM Tris-HCl, pH 7.4), and placed at 48C overnight. Radioactivity in the cells was measured by liquid scintillation counting.
Treatment of the cells
The concentrations of compounds to be tested were chosen based on previous work of our group . In order to test the short-term effect of compounds, cells were exposed to the compounds in GF-HBS buffer during the pre-incubation and incubation periods (corresponding to 30 and 23 min exposure times in 3 H-DG and 14 C-BT experiments, respectively).
In order to test the long-term effect of compounds, cells were exposed to the compounds for 24 h in serum-free culture medium, and during the pre-incubation and incubations periods in GF-HBS buffer (corresponding to 30 and 23 min exposure times in 
Protein determination
The protein content of cell monolayers was determined as described by Bradford (1976) , using human serum albumin as standard.
Determination of cell viability
The short-and long-term effect of compounds upon the viability of HTR-8/ SVneo cells was determined spectrophotometrically by measuring the cellular leakage of the cytosolic enzyme lactate dehydrogenase (LDH) into the extracellular medium. This was done by quantification of the decrease in absorbance of NADH during the reduction of pyruvate to lactate, as described by Bergmeyer and Bernt (1974) .
Determination of cell proliferation rates
Cell proliferation rates were determined with the 3 H-thymidine incorporation assay. Briefly, HTR-8/SVneo cells treated for 24 h with XH (or the respective solvent) were incubated with 3 H-thymidine 0.025 mCi/ml during the last 5 h of the 24-h incubation period. After removal of excess 3 H-thymidine by a 10% TCA (300 ml) wash for 1 h at 48C, drying for 30 min and addition of 280 ml of NaOH 1 M, the incorporated 3 H-thymidine was measured by liquid scintillometry.
Determination of culture growth
Culture growth was determined by the sulforhodamine B (SRB) assay. Briefly, HTR-8/SVneo cells were treated for 30 min or 24 h with XH (or the respective vehicle). At the end of treatment, 62.5 ml of ice-cold 50% (w/v) TCA were added to the culture medium (500 ml) in each well to fix cells (1 h at 48C in the dark). The plates were then washed five times with tap water to remove TCA. Plates were air-dried and then stained for 15 min with 0.4% (w/v) SRB dissolved in 1% (v/v) acetic acid. SRB was removed, and cultures were rinsed four times with 1% (v/v) acetic acid to remove residual dye. Plates were again air-dried, and the bound dye was then solubilized with 375 ml of 10 mM Tris -NaOH solution (pH 10.5). The absorbance of each well was determined at 540 nm; samples were diluted to obtain absorbance values ,0.7.
Determination of migration rates
Cell migration rate was determined by the in vitro wound healing assay. Briefly, HTR-8/SVneo cell monolayers were scratched with a 10 ml pipette tip and were afterwards treated for 24 h with XH (or the respective vehicle). Images were obtained at 0, 6, 12 and 24 h of treatment and quantification was performed by using the ImageJ software (Reinhart-King, 2008; Negrão et al., 2013) .
Glucose metabolism assessment
Glucose metabolism was assessed by quantification of lactate in the extracellular medium of HTR-8/SVneo cells treated with XH (or vehicle) for 30 min or 24 h. At the end of treatment, extracellular medium was collected and centrifuged at 8000 × g for 10 min. Lactate concentration was then measured by the lactate oxidase/peroxidase colorimetric assay, as indicated by the manufacturer (Olympus Life and Material Science Europa GmbH, Hamburg, Germany).
RNA extraction and real-time qPCR
Total RNA was extracted from HTR-8/SVneo cells treated for 24 h with XH (or vehicle), using RNA-STAT 60 TM isolation reagent, according to manufacturer's instructions (Amsbio, AMS Biotechnology (Europe) Limited, UK). Before cDNA synthesis, total RNA was treated with DNAse I (Ambion, Inc., TX, USA) and 1 mg of the resulting DNA-free RNA was reverse transcribed using qScript cDNA SuperMix (Quanta Biosciences, Gaithersburg, MD, USA) in 20 ml of final reaction volume, according to manufacturer's instructions. For real-time qPCR (qRT -PCR), 2 ml of the 20 ml reverse transcription reaction mixture was used. For the calibration curve, HTR-8/SVneo standard cDNA was diluted in six different concentrations. qRT-PCR was carried out using a LightCycler w 96 (Roche, Nutley, NJ, USA). Ten microliter reactions were setup in 96-well plates using 10 mM of each primer and 5 ml of KAPA SYBR w FAST qPCR Master Mix (KAPA SYBR w FAST qPCR Kit Master Mix Universal, Kapa Biosystems, Wilmington, MA, USA), according to manufacturer's instructions. Cycling conditions for human GLUT1 amplification were as follows: denaturation (958C for 5 min), amplification and quantification [958C for 10 s, annealing temperature (AT) for 10 s, and 658C for 10 s, with a single fluorescence measurement at the end of the 728C for 10 s segment] repeated 55 times, followed by a melting curve program [(AT + 10)8C for 15 s and 758C with a heating rate of 0.18C/s and continuous fluorescence measurement] and a cooling step to 378C. The primer pair used for human GLUT1 amplification was 5 ′ -GAT GAT GCG GGA GAA GAA GGT-3 ′ (forward) and 5 ′ -ACA GCG TTGA TGC CAG ACA G-3 ′ (reverse). The amount of GLUT1 mRNA was normalized to the amount of mRNA of the housekeeping gene, human b-actin. Cycling conditions for human b-actin amplification were as follows: denaturation (958C for 5 min), amplification and quantification (958C for 10 s, AT for 10 s, and 658C for 10 s, with a single fluorescence measurement at the end of the 728C for 10 s segment) repeated 45 times, followed by a melting curve program [(AT + 10)8C for 15 s and 758C with a heating rate of 0.18C/s and continuous fluorescence measurement] and a cooling step to 378C; the primer pair used for b-actin was: 5 ′ -AGA GCC TCG CCT TTG CCG AT-3 ′ (forward) and 5 ′ -CCA TCA CGC CCT GGT GCC T-3 ′ (reverse). Data were analyzed using the LightCycler w 96 SW 1.1 analysis software (Roche, Mannheim, Germany), and results analyzed by the Ct method (Schmittgen and Livak, 2008) . b-Actin mRNA expression levels were not affected by treatment of the cells with XH (data not shown).
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Western blotting assay
Proteins were extracted from HTR-8/SVneo cells previously treated for 24 h with vehicle or XH, using RIPA isolation reagent, according to manufacturer's instructions (Roche Diagnostics, Mannheim, Germany). Protein concentration was quantified using the Pierce BCA Protein Assay Kit. Equal amounts of protein (20 mg of protein) were subjected to 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis with a 5% stacking gel. After electrophoresis, proteins were blotted into a Hybond nitrocellulose membrane (Hybond TM -C extra, Amersham Biosciences, Hammersmith, UK), using a mini-transblot electrophoretic transfer cell (Amersham Biosciences, Pittsburg, PA, USA). Immunodetection for GLUT1 and b-actin (Santa Cruz Biotechnology, Inc., CA, USA), was accomplished with enhanced chemiluminescence (ECL kit, Amersham Biosciences, Pittsburg, PA, USA). The relative intensity of each protein was measured using a computerized software program (Biorad, CA, USA) and normalized with b-actin bands to compare the expression of proteins in the different treatment groups.
Calculations and statistics
For the analysis of the time-course of 3 H-DG uptake, the parameters of the equation (A(t) = k in /k out (1 − e −kout.t )) were fitted to the experimental data by a non-linear regression analysis, using a computer-assisted method (Muzyka et al., 2009) . A(t) represents the accumulation of 3 H-DG at time t, k in and k out the rate constants for inward and outward transport, respectively, and t the incubation time. A max is defined as the accumulation at steady state (t 1). For the analysis of the saturation curve, the parameters of the Michaelis -Menten equation were fitted to the experimental data by using a non-linear regression analysis, using a computer-assisted method (Muzyka et al., 2009) . For calculation of IC 50 values, corresponding to the concentration of drug causing 50% of its maximal effect, the parameters of the Hill equation were fitted to the experimental data by using a non-linear regression analysis, using a computer-assisted method (Muzyka et al., 2009) .
Arithmetic means are given with SEM and geometric means with 95% confidence intervals. The value n represents the number of replicates of at least two different experiments. A statistical significance of the difference between two groups was evaluated by the Student's t-test and statistical significance of the difference between three or more groups was evaluated by one-way analysis of variance, followed by the Bonferroni test (GraphPad Prism, Graphpad Software, Inc., La Jolla, CA, USA). Differences were considered to be significant when P , 0.05.
Results
H-DG uptake is time-dependent and saturable
In a first series of experiments, we determined the time-course of (Fig. 1 inset) , after which uptake reached a plateau. Thus, in subsequent experiments, initial rates of H-DG (1-10 000 mM) uptake was saturable, with the following kinetic parameters: V max of 63 + 4.8 nmol mg prot 21 10 min 21 and K m of 2.9 + 0.5 mM. H-DG uptake was not reduced when extracellular sodium was replaced by Li + (Fig. 2B) , the putative involvement of SGLT1 in 3 H-DG uptake was excluded, and it can be concluded that 3 H-DG uptake by HTR-8/SVneo cells involves a GLUT transporter. Finally, the lack of effect of insulin (Fig. 2C) , which his known to stimulate GLUT4-and GLUT12-mediated glucose transport, excludes the involvement of these transporters. We thus conclude that 3 H-DG uptake by these cells involve a member of the GLUT family of transporters distinct from GLUT4 and GLUT12, which most probably corresponds to GLUT1.
Several distinct compounds interfere with 3 H-DG uptake
Therapeutic drugs, drugs of abuse and hormones
The short-term (30 min) effect of some drugs of abuse (nicotine (100 mM), cocaine (25 mM), MDMA (10 mM), amphetamine (25 mM) and ethanol (100 mM)) on 3 H-DG uptake was investigated. None of these drugs had any significant effect upon 3 H-DG uptake (data not shown). Interestingly, short-term FLUOX (100-300 mM) reduced 3 H-DG uptake. This effect is not related to an increase in 5-HT concentration because serotonin (5-hydroxytryptamine; 5-HT) itself was devoid of effect (Fig. 3A) . Moreover, DEXA reduced 3 H-DG uptake in a concentration-independent manner, while MELAT did not affect it (Fig. 3B) .
Dietary compounds
The short-term effect of some dietary polyphenols (QUE, EGCG, XH and RESV) and methylxanthines (CAF and TEO) on 3 H-DG uptake by HTR-8/SVneo cells was also assessed. Interestingly, all these compounds significantly reduced 3 H-DG uptake, with the polyphenols presenting a very marked and concentration-dependent inhibitory effect (Fig. 4) . The inhibitory effect of the polyphenols was not related to a decrease in cell viability, as none of them, when tested in the highest concentration (QUE and EGCG: 1000 mM; XH and RESV: 500 mM), showed a cytotoxic effect in the LDH leakage assay (control: 24.1 + 4.9% total; QUE: 21.9 + 5.4% of total; EGCG: 26.2 + 4.2% of total; XH: 31.6 + 7.6% of total and RESV: 20.6 + 5.0% of total; n ¼ 7-8).
In the presence of CYT B (50 mM), an inhibitor of GLUT-mediated glucose transport, none of the polyphenols was able to further decrease the uptake of 3 H-DG (Fig. 5) , suggesting that these dietary compounds inhibit GLUT-mediated 3 H-DG uptake.
XH is a potent non-competitive inhibitor of 3 H-DG uptake
We next determined the potency of the polyphenols in relation to inhibition of 3 H-DG uptake by HTR-8/SVneo cells. Analysis of inhibition curves after short-term exposure to the polyphenols allowed the calculation of IC 50 values for RESV, XH and EGCG, which are displayed in Fig. 6A and Table I . As shown in Table I , XH was the most potent inhibitor of 3 H-DG uptake by HTR-8/SVneo cells. The effect of short-term exposure to XH upon the kinetic parameters of 3 H-DG uptake by HTR-8/SVneo cells was also evaluated. XH was found to be a noncompetitive inhibitor 3 H-DG uptake by HTR-8/SVneo cells (Table II) .
A longer-term (24 h) exposure of the cells to XH (0.03-5 mM) was also tested. Although with a lower potency, this polyphenol was also able to reduce 3 H-DG uptake by these cells (Fig. 6B ) and it behaved (5 mM; 24 h) as a non-competitive inhibitor of 3 H-DG uptake as well (results not shown)
Inhibition of 3 H-DG uptake by XH involves mTOR, TK and c-JNK signaling pathways
Interestingly enough, the effect of XH (5 mM; 24 h) upon 3 H-DG uptake was reversed by genistein (10 mM), SP 600125 (5 mM) and rapamycin (100 nM), indicating the involvement of tyrosine kinases (TKs), c-Jun N-terminal kinases (JNK) and mammalian target of rapamycin (mTOR) intracellular pathways, respectively (Fig. 7) . The involvement of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) was excluded due to the lack of efficiency of LY 294002 in reversing the effect of XH. H-DG for 10 min: (A) in the presence of 1 mM phloridzin (PHZ; n ¼ 10), 50 or 100 mM cytochalasin B (CYT B; n ¼ 5-10), 0.5 or 1 mM phloretin (PHT; n ¼ 5-10) or the respective solvents (control, indicated by the dashed line; n ¼ 10); (B) in buffer containing sodium chloride (NaCl; n ¼ 9) or an isotonic concentration of lithium chloride (LiCl; n ¼ 9); or (C) in the presence of insulin 100 nM (INS; n ¼ 9) or the respective solvent (control, C; n ¼ 9). Shown are arithmetic means + SEM. *P , 0.05 significantly different from control (Student's t test).
The effect of xanthohumol in first-trimester trophoblasts Figure 3 3 H-DG uptake by HTR-8/SVneo cells is inhibited by short-term exposure to fluoxetine and dexamethasone. Cells were preincubated for 20 min and then incubated with 10 nM 3 H-DG for 10 min: (A) in the presence of 100 -1000 mM fluoxetine (FLUOX; n ¼ 3 -16), 100 -1000 mM serotonin (5-HT; n ¼ 3) or the respective solvents (control, indicated by the dashed line; n ¼ 12 -13); or (B) in the presence of 100 -1000 mM dexamethasone (DEXA; n ¼ 9 -12), 10 nM melatonin (MELAT; n ¼ 6) or the respective solvents (control, indicated by the dashed line; n ¼ 12 -15). Shown are arithmetic means + SEM. *P , 0.05 significantly different from control (Student's t test).
Figure 4
3 H-DG uptake by HTR-8/SVneo cells is inhibited by short-term exposure to dietary polyphenols and methylxanthines. Cells were preincubated for 20 min and then incubated with 10 nM 3 H-DG for 10 min in the presence of 30 -1000 mM quercetin (QUE; n ¼ 6 -15), 30-1000 mM epigallocatechin-3-gallate (EGCG; n ¼ 6 -15), 1 -500 mM xanthohumol (XH; n ¼ 8-10), 1 -500 mM resveratrol (RESV; n ¼ 8 -11), 100-1000 mM caffeine (CAF; n ¼ 11 -12) or 100 -1000 mM theophylline (TEO; n ¼ 11 -12) or the respective solvents (control, indicated by the dashed line; n ¼ 11 -30). Shown are arithmetic means + SEM. *P , 0.05 significantly different from control (Student's t test).
Changes in GLUT1 gene expression and protein levels do not seem to underlie the inhibitory effect of XH upon 3 H-DG uptake XH (5 mM; 24 h) did not alter GLUT1 gene expression (mRNA) levels (Supplementary data, Fig. S1A ), and although we found a tendency for a decrease in GLUT1 protein levels, it was not statistically significant (Supplementary data, Fig. S1B ).
XH interferes with monocarboxylate transporter 1-mediated lactate cellular uptake Knowing that XH reduces 3 H-DG cellular uptake by HTR-8/SVneo cells, interference of cellular glucose metabolism by this compound was next investigated, by quantifying lactate levels. Surprisingly, a shortterm (30 min) exposure to XH (100 mM) led to an increase in the extracellular concentration of lactate (from 100 + 4% to 133 + 6% of control; n ¼ 8), which was much more pronounced after a longer exposure of the cells to this compound (24 h; XH 5 mM) (from 100 + 1% to 285 + 21% of control; n ¼ 8). We hypothesized that XH is interfering with monocarboxylate transporter 1 (MCT1)-mediated cellular reuptake of released lactate. Confirmation of this hypothesis was obtained with the observation that short-term XH (30 min; 100 mM) significantly reduced the cellular uptake of a well-known MCT1 substrate, 14 C-BT (10 mM) (to 54 + 5% of control, n ¼ 12) (data not shown).
XH exerts antiproliferative, cytotoxic and antimigratory effects
A 24 h-exposure of HTR-8/SVneo cells to XH (5 mM) induced a very marked reduction in cell proliferation rate (Fig. 8A) , cell viability (Fig. 8B) , cell culture growth (Fig. 8C ) and cell migration capacity ( Fig. 8D and E) .
The antiproliferative and cytotoxic effect of XH is dependent on inhibition of glucose uptake
Interestingly, low extracellular glucose conditions were able to mimic the effect of XH (5 mM) upon cell viability and culture growth ( Fig. 9A  and B) , suggesting that the antiproliferative and cytotoxic effect of XH is dependent on inhibition of glucose entry and thus related to glucose The effect of xanthohumol in first-trimester trophoblasts cellular deprivation. A further confirmation of this hypothesis was the observation that high glucose conditions were able to reverse the effect of XH in relation to cell viability and culture growth ( Fig. 9C and D) . However, low extracellular glucose conditions did not mimic, and high glucose conditions did not reverse, the effect of XH (5 mM) upon cell migration ( Fig. 9 E and F) . These findings suggest that the antimigratory effect of XH is not dependent on inhibition of glucose entry and thus is not related to glucose cellular deprivation.
Discussion
Uptake of glucose by term trophoblasts and its modulation by xenobiotics has been previously studied by our group. We have verified that dietary compounds such as RESV, XH, EGCG, QUE and TEO decreased 3 H-DG uptake by a human choriocarcinoma cell line .
In the present study, we intended to extend that previous investigation, by characterizing glucose uptake and its modulation by endo and xenobiotics in first-trimester EVTs. The compounds tested included the serotonergic agents serotonin and FLUOX, the hormones DEXA and MELAT, several dietary compounds (polyphenols: QUE (a flavonol), EGCG (a flavan-3-ol), XH (a chalchone) and RESV (a stilbene) and methylxanthines (CAF and TEO) and the drugs of abuse amphetamine, MDMA, nicotine, cocaine and ethanol. The cell line HTR-8/SVneo has been established by transfecting normal first-trimester trophoblasts with a plasmid containing the gene for the simian virus 40 (SV40) large T antigen (Tag). This cell line retains the epithelial phenotype and the proliferative and invasive characteristics of EVTs, thus being an accepted in vitro model system for the study of EVTs characteristics (Graham et al., 1993) .
For glucose transport experiments, 3 H-DG was used. This compound is a glucose analog efficiently transported by GLUT family members, but a very poor SGLT substrate (Wright et al., 2003) , and is not metabolized by phosphoglucose isomerase (Dwarakanath, 2009) .
3 H-DG uptake by HTR-8/SVneo cells was found to be time-dependent, saturable, inhibited by CYT B, PHT and PHZ, insulin-insensitive and sodiumindependent. These characteristics led us to conclude that a GLUT transporter is the main mediator of DG uptake by HTR-8/SVneo cells, most probably GLUT1 since this transporter is highly expressed in this cell line (Belkacemi et al., 2005) and it is known to be critical for glucose uptake in placenta throughout pregnancy (Illsley, 2000) . A short-term exposure of HTR-8/SVneo cells to FLUOX (100-1000 mM) inhibited 3 H-DG uptake. FLUOX is an antidepressant drug that belongs to the selective serotonin reuptake inhibitors (SSRI) class. However, the effect of FLUOX upon 3 H-DG uptake does not appear to be related to its effect upon the serotonin transporter (SERT), as serotonin (100-1000 mM) did not alter 3 H-DG uptake. During pregnancy and in the immediate post-natal period, 10% of women present a major depressive disorder (Belik, 2008) , and it is estimated that 2 -3% of pregnant women receive SSRI antidepressive treatment (Belik, 2008) . We show here that administration of these drugs can impact EVTs nutrition. Additionally, a short-term exposure of HTR-8/SVneo cells to the synthetic glucocorticoid DEXA (100-1000 mM) was also found to induce a concentration-dependent inhibition of 3 H-DG uptake. An inhibitory effect of DEXA in relation to glucose uptake has previously been described in other cell types, namely in 3T3 -L1 adipocytes (Houstis et al., 2006) , associated with a repression of GLUT4 expression (Sangeetha et al., 2013) , and in rat PC12 chromaffin tumor cells, associated with a reduction in GLUT3 protein expression (Liu et al., 2014) . This is interesting, as DEXA administration during pregnancy is commonly used to induce fetal lung maturation (Brownfoot et al., 2013) . As recently reviewed by us (Correia-Branco et al., 2015) , fetal exposure to DEXA can have several developmental programing adverse effects upon fetal health, including development of insulin resistance in adulthood. In this context, our results may provide a mechanism linking fetal exposure to DEXA to the developmental programing of insulin resistance. Finally, a short-term exposure of HTR-8/SVneo cells to the polyphenols QUE (30-1000 mM), EGCG (30-1000 mM), XH (1 -500 mM) and RESV (1-500 mM) and to the methylxanthines CAF (100-1000 mM) and TEO (100-1000 mM) induced a concentration-dependent inhibition of 3 H-DG uptake. These results go in line with previous studies showing a glucose uptake inhibitory effect of these compounds in other cell lines. For instance, our group found an inhibitory effect of these polyphenols upon 3 H-DG uptake by a human term trophoblast cell line (BeWo cells), although the methylxanthines were devoid of effect . Moreover, QUE and EGCG were found to reduce glucose uptake by MCF7 breast cancer cells (Moreira et al., 2013) , and QUE reduced glucose uptake by another breast cancer cell line (MDA-MB-231 cells), associated with a decrease in cell membrane translocation of GLUT4 (Wang and Yang, 2014) . Also, an inhibitory effect of QUE and EGCG upon glucose uptake and GLUT4 expression was observed in a mouse preadipocyte cell line, MC3T3-G2/PA6 (Nomura et al., 2008) and in isolated rat adipocyte cells (Strobel et al., 2005) . As for RESV, it was reported to inhibit glucose uptake in Lewis lung carcinoma, HT-29 colon, and in T47D breast cancer cells, but the identity of the transporter(s) involved was not reported (Jung et al., 2013) . As for the methylxanthines, CAF and TEO were previously found to inhibit glucose uptake by noncompetitive inhibition of GLUT1 in unsealed erythrocyte ghosts from washed red blood cells (Ojeda et al., 2012) and CAF inhibited glucose uptake and suppressed insulin-induced GLUT4 translocation in mouse preadipose MC-3T3-G2/PA6 cells (Akiba et al., 2004) .
Among all the compounds tested, XH was the most potent inhibitor of 3 H-DG uptake by HTR-8/SVneo cells. XH is a structurally simple prenylated chalcone that occurs only in the hop plant, Humulus lupulus L. (Cannabaceae), where it is the principal prenylflavonoid of the female inflorescences (usually referred to as 'hops' or 'hop cones'), and is used to add bitterness and flavor to beer (Stevens and Page, 2004) . The effect of this chalcone was very potent: exposure to XH inhibited 3 H-DG uptake (IC 50 of 3.55 mM) in a concentration-dependent manner, and it behaved as a noncompetitive inhibitor (decreasing V max while not affecting the Km of 3 H-DG uptake).
The effect of XH was consistent as long-term (24 h) exposure of HTR-8/SVneo cells to this chalcone was also able to induce a reduction in 3 H-DG uptake in a noncompetitive manner. Interestingly enough, this effect was associated neither with a decrease in GLUT1 mRNA expression levels nor with a decrease in GLUT1 protein levels, suggesting that the reduction of 3 H-DG transport induced by XH is related to changes in the intrinsic activity of the GLUT1 transporter. Moreover, we could Figure 7 The inhibitory effect of long-term exposure to XH upon 3 H-DG uptake by HTR-8/SVneo cells involves mammalian target of rapamycin, tyrosine kinase and c-Jun N-terminal kinase signaling pathways. Cells were preincubated for 24 h in serum-free culture medium and then incubated with 10 nM 3 H-DG for 10 min, in the absence or presence of 5 mM XH (n ¼ 11 -21) and (A) genistein (GEN; 10 mM; n ¼ 12) or LY 294002 (LY; 1 mM; n ¼ 9); or (B) SP 600125 (SP; 5 mM; n ¼ 12) or rapamycin (RAPA; 100 nM; n ¼ 9). Shown are arithmetic means + SEM. *P , 0.05 significantly different from control (dashed line), # P , 0.05 significantly different from XH 5 mM (one-way analysis of variance followed by Bonferroni test).
The effect of xanthohumol in first-trimester trophoblasts conclude that the inhibitory effect of XH upon 3 H-DG uptake involves the intracellular signaling pathways mTOR, TK and JNK, but not PI3K. Interestingly enough, in a recent study in brown adipose tissue, it was shown that GLUT1 transcription and de novo synthesis of GLUT1 are mediated by mTOR and independent of the classical insulin-PI3K pathway (Olsen et al., 2014) . Also, it has been described that several TK inhibitors, either synthetic (such as the tyrphostins) or natural products of the family of flavones and isoflavones (including genistein), are able to impair GLUT1 activity, apparently by competition with the ATP binding site of GLUT1 (Vera et al., 2001) . In the last part of this work, the relationship between inhibition of glucose uptake by XH and the placentation process was investigated. The long-term (24 h) exposure of the cells to this dietary polyphenol caused a significant decrease in cell viability, culture growth, proliferation and migration. By showing that low extracellular glucose mimics the effect of XH upon cell viability and culture growth, and that high extracellular glucose reverses these effects of XH, we can conclude that the antiproliferative and cytotoxic effects of XH are dependent upon glucose deprivation of HTR-8/SVneo cells. However, these findings do not apply to the antimigratory effect of XH, suggesting that this effect is not dependent upon glucose deprivation of HTR-8/SVneo cells.
It is interesting to observe that XH, a polyphenol with a chemopreventive effect (Gerhauser et al., 2002; Vene et al., 2012; Wyns et al., 2012; Blanquer-Rossello et al., 2013; Kim et al., 2013; Tronina et al., 2013) , shows a similar effect in relation to EVT proliferation, culture growth, cell viability and migration. Also, changes in viability, culture growth, proliferation and migration after exposure of HTR-8/SVneo cells to XH are Figure 9 The antiproliferative and cytotoxic effect, but not the antimigratory effect of XH is dependent on inhibition of glucose uptake by HTR-8/SVneo cells. Cells were exposed to 5 mM XH or the respective solvent for 24 h in low glucose conditions (LG+C, 1 mM), normal glucose conditions (NG+C, 11 mM) or high glucose conditions (HG+C, 20 mM). Low extracellular glucose conditions mimic the effect of 5 mM XH upon cell viability (Panel A; n ¼ 12) and culture growth (Panel C; n ¼ 12), but not cell migration (Panel E; . High glucose conditions revert the effect of 5 mM XH upon cell viability (Panel B; n ¼ 12) and culture growth (Panel D; n ¼ 12), but not cell migration (Panel F; . Shown are arithmetic means + SEM. *P , 0.05 significantly different from control (NG+C); ns ¼ not significantly different from each other; # P , 0.05 significantly different from each other (Student's t test).
The effect of xanthohumol in first-trimester trophoblasts similar to the phenotype observed in insufficient EVTs from pregnancyrelated pathologies such as FGR. Indeed, EVT insufficiency and inadequate placentation, characterized by shallow cellular viability, proliferation, migration, invasion and angiogenesis, is believed to be an underlying mechanism of FGR (Fisher, 2004) . As such, exposing HTR-8/SVneo cells to XH could provide a means to develop an experimental cell model of first-trimester insufficient EVTs, which is presently still lacking. Inhibition of glucose uptake is expected to be associated with a consequent reduction in glucose metabolism and thus in lactate production. However, contrary to our expectations, exposure of cells to XH either for short-term (30 min) or for long term (24 h) induced a very marked increase in the amount of extracellular lactate levels. We hypothesized that this observation is related to an inhibitory effect of XH upon MCT1-mediated reuptake of lactate. The observation that XH was indeed able to reduce MCT1-mediated uptake of 14 C-BT supported our hypothesis. We then conclude that XH inhibits MCT1-mediated lactate reuptake by HTR-8/SVneo cells. By inhibiting lactate reuptake in these cells, XH may also starve cells of lactate, which thus further contributes to cell death.
In conclusion, XH seems to be a potent noncompetitive inhibitor of glucose uptake by HTR-8/SVneo cells, either after short-or long-term exposure, and this effect of XH seems to involve mTOR, TK and JNK intracellular pathways. In addition, the antiproliferative and cytotoxic effects of XH in these cells are related to cellular glucose deprivation, as they were mimicked by low extracellular glucose conditions and reversed by high glucose extracellular conditions. Furthermore, XH increases extracellular lactate levels, associated with an inhibition in MCT1-mediated lactate cellular reuptake, pointing to an alteration of both glucose and lactate handling by these cells. As such, this study contributes to a deeper knowledge of the impact of XH upon the placentation process and consequently the nefarious impact upon fetal and maternal health, which can have long-term consequences upon the developmental programing effects of disease (Correia-Branco et al., 2015) .
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